ALL PRODUCTS ARE STRICTLY FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.
Applications

Where Our Materials Fit Your Protocol

PeptideLab supplies documented RUO lyophilized compounds for in-vitro and approved preclinical workflows — not patient care.

RUO only. Educational content on this site does not constitute medical advice. Products are not for human injection, consumption, or pharmacy substitution.


Metabolic & endocrine research

Universities and CROs model incretin pathways with tirzepatide, semaglutide, and retatrutide reference material. Typical endpoints: insulin sensitivity, hepatic lipid handling, appetite circuit reporters, and body-composition surrogates in animal models under IACUC.

  • Post-menopausal metabolic shift models (estrogen decline + visceral adiposity markers)
  • Head-to-head dual vs triple agonist arms with matched lot potency
  • Combination studies with hormone-replacement contexts — protocol design stays with your PI

Obesity & cardiometabolic disease models

Published GLP-1 demand reflects both clinical shortages and bench interest. We help labs source consistent HPLC identity so week-to-week assay readouts stay comparable — without positioning material as a consumer weight-loss product.

Healing, recovery & tissue repair

BPC-157, TB-500, and related sequences support wound-healing and musculoskeletal research lines. Identity and endotoxin screening matter when moving from cells to rodent models.

Sports science & physiology labs

Some institutions study GH secretagogues and recovery peptides in exercise physiology. We label clearly as RUO and do not market to athletes for personal use.

What we do not support

No DIY injection guides, no sterile-water mixing instructions for human use, and no off-label pharmacy substitution. If your use case is personal weight management, this catalog is not for you.

    Chat with us